June 11, 2026

The African Tribune

Bold, independent reporting on Africa's most important stories, in English, every day.

Gabon tightens controls on iboga exploitation and trade

The Gabonese government has taken decisive steps to regulate the exploitation and commercialization of iboga, a Central African shrub renowned for its psychoactive and therapeutic properties. Authorities in Libreville have now imposed strict licensing requirements for all activities involving this emblematic plant, which has seen its global economic value surge over the past decade.

Iboga: a national treasure now under state supervision

Tabernanthe iboga, a shrub native to Gabon’s equatorial forests, holds a unique place in the country’s cultural and natural heritage. It is central to the bwiti initiation rites and is increasingly studied in international biomedical research for its potential in treating opioid and cocaine addictions. This dual significance—both cultural and pharmacological—has attracted significant foreign interest, often leading to unregulated harvesting of wild populations.

In response, the Gabonese government now mandates that all iboga-related activities, including harvesting, processing, transfer, and export, require prior administrative authorization. This measure builds on existing protections, including the plant’s designation as a national cultural heritage in 2000. Without official validation, no commercial operations will be permitted, and violations will incur penalties.

Biological sovereignty and the fight against biopiracy

The move addresses long-standing concerns about foreign entities profiting from Gabon’s iboga resources without benefiting local communities or the state. Clinics in Europe and North America have long offered ibogaine-based therapies—derived from the plant’s root—at premium prices, yet much of the raw material originates from Gabon’s forests, where unregulated harvesting threatens the species’ survival.

By tightening regulations, Libreville aims to track iboga flows, enforce harvest quotas, and negotiate access and benefit-sharing agreements under the Nagoya Protocol, to which Gabon is a signatory. This approach aligns with efforts by other Congo Basin countries to protect their genetic resources. However, enforcing these rules across Gabon’s vast and inaccessible forest zones remains a challenge, where illegal trade in non-timber forest products persists.

Balancing tradition and industry in iboga’s future

Beyond enforcement, the new framework seeks to structure a national iboga industry. Traditional practitioners, village cooperatives, and industrial actors must now navigate a defined administrative process. The country faces a dual challenge: safeguarding natural populations, which regenerate slowly, while capturing the added value of a plant increasingly sought after by global pharmaceutical research.

Key questions remain unanswered: What criteria will determine authorization eligibility? Which ministry will oversee application reviews? How will traditional knowledge holders tied to bwiti be included? The system’s credibility hinges on transparent procedures and the government’s ability to balance economic interests with conservation needs.

For international investors and partners, the message is clear: iboga is no longer a freely accessible resource. Gabon, which has intensified efforts to valorize its natural capital—from carbon credits to forest certification—adds another layer to its ecological sovereignty strategy. The success of this reform will depend on the human and technical resources Gabon dedicates to its implementation. The new authorization regime is already in effect.